<http://dbpedia.org/resource/AM-2201>	<http://xmlns.com/foaf/0.1/depiction>	<http://commons.wikimedia.org/wiki/Special:FilePath/AM-2201_structure.png> .
<http://dbpedia.org/resource/AM-2201>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://dbpedia.org/resource/JWH-018> .
<http://dbpedia.org/resource/AM-2201>	<http://dbpedia.org/ontology/casNumber>	"335161-24-5" .
<http://dbpedia.org/resource/AM-2201>	<http://www.w3.org/2000/01/rdf-schema#comment>	"AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) is a recreational designer drug that acts as a potent but nonselective full agonist for the cannabinoid receptor. It is part of the AM series of cannabinoids discovered by Alexandros Makriyannis at Northeastern University."@en .
<http://dbpedia.org/resource/AM-2201>	<http://dbpedia.org/ontology/iupacName>	"1-[(5-Fluoropentyl)-1H-indol-3-yl]-(naphthalen-1-yl)methanone"@en .
<http://dbpedia.org/resource/AM-2201>	<http://dbpedia.org/ontology/thumbnail>	<http://commons.wikimedia.org/wiki/Special:FilePath/AM-2201_structure.png?width=300> .